Ye Jason C, Qureshi Muhammad M, Clancy Pauline, Dise Lauren N, Willins John, Hirsch Ariel E
1 Department of Radiation Oncology, Boston Medical Center and Boston University School of Medicine, Boston, MA 02118, USA ; 2 Department of Radiation Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10065, USA.
Quant Imaging Med Surg. 2015 Oct;5(5):665-72. doi: 10.3978/j.issn.2223-4292.2015.10.01.
This study examined the interfraction setup error in patients undergoing prostate radiotherapy using fiducial markers and on-board imaging.
Patients (n=53) were aligned to the treatment isocenter by laser followed by orthogonal kilovoltage (kV) radiographs to visualize bony anatomy and implanted fiducial markers. The magnitude and direction of couch shifts for isocenter correction required was determined by image registration for bony anatomy and fiducial markers. Twice weekly, 25 of the 53 patients also underwent conebeam computed tomography (CBCT) to measure any residual error in patient positioning. Based on individual coordinate shifts from CBCT, a net three-dimensional (3D) residual shift magnitude vector R was calculated.
The average couch shifts were 0.26 and 0.40 cm in inferior direction and 0.25 and 0.33 cm in superior direction for alignments made with bony anatomy and fiducial markers, respectively (P<0.0001). There were no significant differences noted in the vertical or lateral planes between the two image registration methods. In subset of 25 patients, no residual shift from fiducial plain film set up was required with CBCT matching in 66.5%, 52.4% and 57.9% of fractions for longitudinal, vertical and lateral planes, respectively, with majority (79%) of patients having a net residual 3D shifts of <0.3 cm. The use of CBCT increased average treatment time by approximately 6 min compared to kV radiographs alone.
The residual setup errors following daily kV image guided localization, as determined by CBCT, were small, which demonstrates high accuracy of kV localization when fiducial markers are present.
本研究使用基准标记和机载成像技术,对接受前列腺放疗的患者的分次间摆位误差进行了检测。
53例患者通过激光与治疗等中心对齐,随后进行正交千伏(kV)射线照相,以观察骨骼解剖结构和植入的基准标记。通过对骨骼解剖结构和基准标记进行图像配准,确定等中心校正所需的治疗床移动幅度和方向。53例患者中有25例每周两次还接受锥形束计算机断层扫描(CBCT),以测量患者定位中的任何残余误差。基于CBCT的个体坐标偏移,计算出净三维(3D)残余偏移幅度向量R。
分别以骨骼解剖结构和基准标记进行对齐时,平均治疗床在下方向的移动分别为0.26 cm和0.40 cm,在上方向的移动分别为0.25 cm和0.33 cm(P<0.0001)。两种图像配准方法在垂直或侧平面上均未观察到显著差异。在25例患者的子集中,在纵向、垂直和侧平面上,分别有66.5%、52.4%和57.9%的分次无需CBCT匹配即可从基准平片摆位产生残余偏移,大多数(79%)患者的净残余3D偏移<0.3 cm。与单独使用kV射线照相相比,使用CBCT使平均治疗时间增加了约6分钟。
CBCT测定的每日kV图像引导定位后的残余摆位误差较小,这表明存在基准标记时kV定位具有较高的准确性。